Search

for
Search:

Glossary

Similar Terms

Learn

0 / 0 results

— no results

Research

5 / 547 results

Breakdown of Immune Tolerance in AIRE-Deficient Rats Induces a Severe Autoimmune Polyendocrinopathy–Candidiasis–Ectodermal Dystrophy–Like Autoimmune Disease

research Breakdown of Immune Tolerance in AIRE-Deficient Rats Induces a Severe Autoimmune Polyendocrinopathy–Candidiasis–Ectodermal Dystrophy–Like Autoimmune Disease

26 citations , June 2018 in “The journal of immunology/The Journal of immunology”

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

research Current Stem Cell Technologies Used in Medicine

3 citations , December 2020 in “Medical Journal of Cell Biology”

Stem cell technologies are mostly effective in treating diseases and repairing tissues.

research Editorial Overview: Embroidering the Canvas of Life

October 2018 in “Current Opinion in Genetics & Development”

The document emphasizes the importance of ongoing research and ethical considerations in genome editing and cellular reprogramming.

research Pre-Clinical Non-Viral Vectors Exploited for In Vivo CRISPR/Cas9 Gene Editing: An Overview

23 citations , January 2022 in “Biomaterials Science”

Non-viral vectors show promise for safe and effective CRISPR/Cas9 gene editing in treating diseases.

Antioxidants and Mitochondrial Bioenergetics: Charnoly Bodies in Neurodegenerative Diseases, Cardiovascular Disorders, and Cancer

research Antioxidants and Mitochondrial Bioenergetics: Charnoly Bodies in Neurodegenerative Diseases, Cardiovascular Disorders, and Cancer

January 2017 in “Elsevier eBooks”

Antioxidants may help improve mitochondrial health and could be used to treat diseases related to cell damage.

View more "nucleases" in research →

Community Join

1 / 1 results

community CRISPR Is Curing People Right Now. Genetic Hair Loss is Next?

in Technology 107 upvotes 1 year ago

CRISPR shows promise for treating hair loss by targeting specific genes. Current treatments include Minoxidil and finasteride, but CRISPR could offer a more precise solution, though it is still expensive and in early stages.